As I return home from the 58th annual American Society of Hematology meeting, there is so much information to digest and process. It was like a cornucopia of data. The #daratumumab information was plentiful – from the Castor and Pollux studies achieving Food and Drug Administration approval for use with Velcade + Dex or Revlimid […]
